What's going on HER2陽性乳癌に対する補助化学療法後のトラスツズマブ投与に関するランダム化比較試験(2年フォローアップの解析)[Smith I, Procter M, Gelber RD, Guillaume S, Feyereislova A, Dowsett M, Goldhirsch A, Untch M, Mariani G, Baselga J, Kaufmann M, Cameron D, Bell R, Bergh J, Coleman R, Wardley A, Harbeck N, Lopez RI, Mallmann P, Gelmon K, Wilcken N, Wist E, Sanchez Rovira P, Piccart-Gebhart MJ; HERA study team'2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial']

Web Site

書誌事項

タイトル別名

What s going on HER2 ヨウセイニュウガンニタイスルホジョカガクリョウホウゴノトラスツズマブトウヨニカンスルランダムカヒカクシケン 2ネンフォローアップノカイセキ Smith I Procter M Gelber RD Guillaume S Feyereislova A Dowsett M Goldhirsch A Untch M Mariani G Baselga J Kaufmann M Cameron D Bell R Bergh J Coleman R Wardley A Harbeck N Lopez RI Mallmann P Gelmon K Wilcken N Wist E Sanchez Rovira P Piccart Gebhart MJ HERA study team 2 year follow up of trastuzumab after adjuvant chemotherapy in HER2 positive breast cancer a randomised controlled trial

記事種別: 書評

Mebio oncology : Principle, practice and research review

Mebio oncology : Principle, practice and research review 4 (2), 85-87, 2007-06

東京 : メジカルビュー社